Lung cancer is the leading cause of all cancer deaths nationwide, and women are 1 1/2 times more likely to get diagnosed with ...

For that study, they analyzed molecular differences between the peripheral blood plasma of lung cancer subjects and noncancer ...

SBRT and hypofractionated CRT produced similar outcomes in patients with inoperable stage I NSCLC in a phase 3 trial.

Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) ("Innate" or the "Company") today released its 2025 financial calendar: ...

Justin Zelin, an analyst from BTIG, reiterated the Buy rating on Mersana Therapeutics (MRSN – Research Report). The associated price ...

The US Preventive Services Task Force recommends that high risk patients between 50 and 80 receive lung cancer screening.

Corvus Pharmaceuticals’ stock surged from under $2 to $10. Learn why CRVS stock is gaining attention with promising pipeline ...

" I’m honored to join Innate Pharma at such a pivotal moment in its evolution,”said Jonathan Dickinson, Chief Executive Officer of Innate Pharma. “ We achieved notable regul ...

ANKET ® ( A ntibody-based NK cell E ngager T herapeutics) is Innate's proprietary platform for developing next-generation, multi-specific natural killer (NK) cell engagers to treat certain types of ...

Soquelitinib Atopic Dermatitis Phase 1 Clinical Trial Enrolling Patients in Second Dosing CohortInterim Data from Atopic Dermatitis Trial ...

In operable non-small cell lung cancer (NSCLC), molecular residual disease (MRD) detection via circulating tumor DNA (ctDNA) has emerged as a promising approach to identify individuals at high risk of ...

If you experience severe or sudden calf pain or suddenly have trouble moving or walking, it’s time to contact a healthcare ...